Search Results

A Phase 2 Study of Intravenous Administration of REOLYSIN (Reovirus Type 3 Dearing) in Combination with Paclitaxel and Carboplatinin Patients with Squamous Cell Carcinoma of the Lung (REO 021)

Disease Types: Lung
Available at: Medical Center,  New Braunfels

A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy (MED)

Disease Types: Supportive Care
Available at: Kerrville,  Medical Center,  Metropolitan,  New Braunfels,  Northeast,  Stone Oak

A Phase III, Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy

Disease Types: Supportive Care
Available at: Medical Center

A Phase III, Randomized Study to Assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib and Dexamethasone in Multiple Myeloma Patients Previously Treated with Bortezomib

Disease Types: Multiple Myeloma
Available at: Kerrville,  Medical Center,  Metropolitan,  New Braunfels,  Northeast,  Stone Oak

Precision Therapeutics Registry Multicenter, Post Market Follow Up Study of ChemoFx Chemo Response Assay in Solid Tumors-ChemoFx Registry Study

Disease Types: Supportive Care
Available at: Medical Center,  New Braunfels

An Open Label Assessment of Alternative Dosing Strategies of Ruxolitinib in Patients with Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis and Post-Essential Thrombocythemia-Myelofibrosis

Disease Types: Primary Myelofibrosis/Post-Essential Myelofibrosis/Post-Polycythemia Vera Myelofibrosis
Available at: Medical Center,  New Braunfels

Open Label Assessment of Safety and Efficacy of Ruxolitinib in Patients with Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis and Post-Polycythemia Vera-Myelofibrosis Who Have Platelet Counts of 50 to 100

Disease Types: Primary Myelofibrosis/Post-Essential Myelofibrosis/Post-Polycythemia Vera Myelofibrosis
Available at: Medical Center,  New Braunfels

Phase II Open-Label Study of Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) Which Has Relapsed After Rituximab Therapy

Disease Types: Lymphoma
Available at: Medical Center,  New Braunfels

A Phase III, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients with First Relapsed or Refractory Acute Myeloid Leukemia

Disease Types: Leukemia (CLL, CML)
Available at: Medical Center

A Phase III Multicenter Randomized, Controlled Study to Assess the Efficacy and Safety of ONO1919/Na Administered as a 72 Hr. Continuous Intravenous Infusion Every Other Week in MDS patients with Excess Blasts Relapsing After, or Refractory to , or Intolerant to Azacitidine or Decitabine

Disease Types: Myelodysplasia
Available at: Medical Center,  New Braunfels

A Randomized, Multicenter Study Comparing Pixantrone + Rituximab with Gemcitabine + Rituximab in Patients With Agressive B-Cell Non-Hodgkins Lymphoma Who Have Relapsed After Therapy with CHOP-R or an Equivalent Regimen and are Ineligible for Stem Cell Transplant

Disease Types: Lymphoma
Available at: Medical Center,  New Braunfels

A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy

Disease Types: Lung
Available at: Kerrville,  Medical Center,  New Braunfels,  Northeast,  Southeast,  Stone Oak

A Randomized, Double Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil Plus Ramucirumab or Placebo in Patients with Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy with Bevacizumab, Oxaliplatin, and a Fluoropyrimidine

Disease Types: Colorectal
Available at: Kerrville,  Medical Center,  Metropolitan,  New Braunfels,  Northeast,  Stone Oak

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Deferasirox in Patients with Myelodysplastic Syndromes (low/int-1 Risk) and Transfusional Iron Overload

Disease Types: Myelodysplasia
Available at: Kerrville,  Medical Center,  New Braunfels,  Northeast,  Stone Oak

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long-Term Safety and Efficacy of Darbepoetin Alfa Administered at 500 ig Once-Every-3-Weeks to a Hemoglobiin Ceiling of 12.0 g/dl in Anemic Subjects with Advanced Stage Non-Small Cell Lung Cancer Receiving Multi-Cycle Chemotherapy

Disease Types: Lung
Available at: Kerrville,  Medical Center,  New Braunfels,  Northeast,  Stone Oak

Single Arm, Open Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of P276-00 in Patients with Relapsed and/or Refractory Mantel Cell Lymphoma

Disease Types:
Available at: Medical Center,  New Braunfels

A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study for the Evaluation of Efficacy and Safey of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects with Symptomatic Deep-Vein Thrombosis and/or Pulmonary Embolism

Disease Types: DVT
Available at: Medical Center,  New Braunfels

A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism

Disease Types: DVT
Available at: Medical Center,  New Braunfels

A Prospective, Randomized Double-Blind, Stratified, Placebo-Controlled, Multi-Center, Three-Arm Trial of the Continued Efficacy and Safety of Zometa (every 4 weeks vs. every 12 weeks vs. placebo) in Patients with Documented Bone Metastases from Breast Cancer

Disease Types: Breast Cancer and Bone Metastases
Available at: Medical Center,  New Braunfels